Janney Montgomery Scott LLC Athersys, Inc Transaction History

Janney Montgomery Scott LLC

  • $32.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019
SELL
$1.41 - $2.16 $3,525 - $5,400
-2,500 Reduced 7.25%
32,000 $46,000
Q3 2018

Nov 05, 2018
BUY
$1.86 - $2.18 $4,650 - $5,450
2,500 Added 7.81%
34,500 $72,000
Q2 2018

Jul 24, 2018
SELL
$1.76 - $2.79 $3,520 - $5,580
-2,000 Reduced 5.88%
32,000 $63,000
Q1 2018

Apr 19, 2018
BUY
$1.34 - $2.03 $45,560 - $69,020
34,000 New
34,000 $62,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email